the HGF mimic compositions (preparations) of the present invention may be administered by any of the many suitable means which are well known to those of skill in the art, including but not limited to: by injection, inhalation, orally, intravaginally, intranasally, by ingestion of a food or product containing the mimic, topically, as eye drops, via sprays, etc
Scaffold-based delivery methods may unlock its full potential for bone regeneration in future clinical applications
DOI:10.2174/1570159X13666160502153022, 3
Additionally, AOD-9604 does not stimulate IGF-1 production or activate growth hormone receptors, pathways that would otherwise affect appetite-regulating neuropeptides